June 6, 2011 (Chicago, Illinois) — Extended adjuvant treatment with imatinib (Gleevec) improves survival in patients with high-risk gastrointestinal stromal tumors (GIST). Imatinib administered for 3 ...
June 5, 2012 (Chicago, Illinois) — A new targeted agent might fulfill an unmet need for patients with gastrointestinal stromal tumors (GIST) that become resistant to current treatment. According to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback